Mikkael A. Sekeres MD
Chief, Division of Hematology; Professor of Medicine Sylvester Comprehensive Cancer Center, University of Miami
Join to View Full Profile
1475 NW 12th AveMiami, FL 33136
Phone+1 305-243-6302
Fax+1 305-243-9161
Dr. Sekeres is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1999 - 2002
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1996 - 1999
Perelman School of Medicine at the University of PennsylvaniaClass of 1996
Certifications & Licensure
FL State Medical License 2020 - 2027
OH State Medical License 2002 - 2022
MA State Medical License 1998 - 2003
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
Clinical Trials
- Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes Start of enrollment: 2004 Feb 01
- Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder Start of enrollment: 2005 Oct 01
- Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia Start of enrollment: 2006 May 01
Publications & Presentations
PubMed
- Modeling the evolutionary dynamics of clonal hematopoiesis.Sadegh Marzban, Thomas Stiehl, Zhuoer Xie, Morten Andersen, Jordan Snyder
Nature Genetics. 2026-02-16 - Conventional Therapy vs HMA or LDAC ± Venetoclax in Older Adults With AML: Systematic Review and Meta-analysis.Sara Ibrahim, Barbara Burgos-Mansilla, Yetiani Roldan, Maria-Jose Oliveros, Gurleen Bhogal
Blood Advances. 2026-02-11 - A novel approach to defining progression in MDS and precursor myeloid conditions in The MDS Natural History Study.Amy E DeZern, Nancy Gillis, Michael Otterstatter, Gregory A Abel, Eric Padron
Blood Advances. 2026-02-11
Journal Articles
- Germline Loss of Function SAMD9 and SAMD9L Alterations in Adult Myelodysplastic SyndromesSamuel Li, Mikkael A Sekeres, Jaroslaw P Maciejewski, Rabi Hanna, Blood
- Relative Survival Following Response to 7 + 3 Versus Azacytidine Is Similar in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes: An Analysis of Four SWOG...Sucha Nand, Mikkael A Sekeres, Nature
- Mutational Landscape of myelodysplastic/myeloproliferative Neoplasm – Unclassifiable (MDS/MPN-U)Aziz Nazha, Rami S Komrokji, Andrew Sochacki, Mikkael A Sekeres, Prithviraj Bose, Courtney D DiNardo, Hagop M Kantarjian, Srdan Verstovsek, Sanam Loghavi, Jaroslaw P M..., Blood
Abstracts/Posters
- Molecular Characterization of Leukemia Evolving from Paroxysmal Nocturnal HemoglobinuriMikkael A. Sekeres, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- TET2 Loss Accelerates Leukemogenesis By Disrupting Mismatch Repair ProteinsMikkael A. Sekeres, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Can Monosomy 7 be Targeted By Next Generation Cereblon-Modulating Agents?Mikkael A. Sekeres, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Myelodysplastic Syndromes: From Mild-Mannered to Lurking Leukemia61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Special Education Session on ASH Clinical Practice Guidelines on Acute Myeloid Leukemia in Older Adults61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Meeting Tips: Giving a Scientific Presentation, Being a Good Discussant and Asking a Question in the Aisle61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Authored Content
- Cancer Patients Often Want ‘One More Round.’ Should Doctors Say No?March 2024
- Watching My Patient Die, RemotelyNovember 2018
- Resolutions of a Cancer DoctorJanuary 2018
Press Mentions
As an Oncologist, These Are the Foods I Recommend to Lower Cancer RiskFebruary 16th, 2026- I’m an Oncologist. Here’s What the Science Says About Cancer and SupplementsFebruary 2nd, 2026
- ASH: Guidelines Updated for Management of Acute Myeloid Leukemia in Older AdultsDecember 10th, 2025
Grant Support
- A Phase I/II Study Of Clofarabine &Cytoside ArabinosideNational Center For Research Resources2006
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
